Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa
BMJ Glob Health
.
2024 Oct 9;9(10):e015445.
doi: 10.1136/bmjgh-2024-015445.
Authors
Alemayehu Lelisa Duga
1
2
,
Ngashi Ngongo
3
,
Mosoka Papa Fallah
3
,
Albert Figueras
2
,
Carlos Kilowe
3
,
Jibril Murtala
3
,
Kizito Kayumba
3
,
Tedi Angasa
3
,
Aminu Kuba
3
,
Patrick Chanda Kabwe
3
,
Nebiyu Dereje
3
,
Tajudeen Raji
3
,
Nicaise Ndembi
3
,
Jean Kaseya
3
Affiliations
1
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
[email protected]
.
2
Doctoral School Societies Politics, Public Health, Pharmacoepidemiology and Pharmacovigilance, University of Bordeaux, Bordeaux, France.
3
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
PMID:
39384330
PMCID:
PMC11474706
DOI:
10.1136/bmjgh-2024-015445
No abstract available
Keywords:
COVID-19; Global Health; Immunisation; Malaria; Vaccines.
MeSH terms
Africa
Humans
Malaria Vaccines*
Malaria* / prevention & control
Substances
Malaria Vaccines